|
|
Dasatinib in high-risk core binding factor acute myeloid leukemia in first complete remission: a French Acute Myeloid Leukemia Intergroup trial
Nicolas Boissel
,
Aline Renneville
,
Thibaut Leguay
,
Pascale Cornillet Lefebvre
,
Christian Recher
,
et al.
Journal articles
inserm-01820455v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Molecular classification and prognosis in younger adults with acute myeloid leukemia and intermediate-risk cytogenetics treated or not by gemtuzumab ozogamycin: Final results of the GOELAMS/FILO acute myeloid leukemia 2006-intermediate-risk trial
Anne Bouvier
,
Jean-Francois Hamel
,
Jacques Delaunay
,
Eric Delabesse
,
Pierre-Yves Dumas
,
et al.
Journal articles
hal-03604930v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Quantitative chimerism in CD3-negative mononuclear cells predicts prognosis in acute myeloid leukemia patients after hematopoietic stem cell transplantation
Anne Bouvier
,
Jeremie Riou
,
Sylvain Thépot
,
Aurélien Sutra del Galy
,
Sylvie Francois
,
et al.
Journal articles
hal-02416159v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Study of mitochondrial function in placental insufficiency
Tiphaine Lefebvre
,
Ombeline Roche
,
Valerie Seegers
,
Majida Cherif
,
Salim Khiati
,
et al.
Journal articles
hal-02388228v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Prognostic impact of day 15 blast clearance in risk-adapted remission induction chemotherapy for younger patients with acute myeloid leukemia: long term results of the multicenter prospective LAM-2001 trial by the GOELAMS study group.
Sarah Bertoli
,
Pierre Bories
,
Marie C Béné
,
Sylvie Daliphard
,
Bruno Lioure
,
et al.
Journal articles
hal-00854975v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Early matched sibling hematopoietic cell transplantation for adult AML in first remission using an age-adapted strategy: long-term results of a prospective GOELAMS study.
Bruno Lioure
,
Marie C Béné
,
Arnaud Pigneux
,
Anne Huynh
,
Patrice Chevallier
,
et al.
Journal articles
hal-00849702v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Prospective long-term minimal residual disease monitoring using RQ-PCR in RUNX1-RUNX1T1-positive acute myeloid leukemia: results of the French CBF-2006 trial
C. Willekens
,
O. Blanchet
,
A. Renneville
,
P. Cornillet-Lefebvre
,
C. Pautas
,
et al.
Journal articles
inserm-01817446v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Sequential mutational evaluation of CALR ‐mutated myeloproliferative neoplasms with thrombocytosis reveals an association between CALR allele burden evolution and disease progression
Laurane Cottin
,
Jeremie Riou
,
Corentin Orvain
,
Jean Christophe Ianotto
,
Françoise Boyer
,
et al.
Journal articles
inserm-02467617v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Screening for therapeutic trials and treatment indication in clinical practice: MACK-3, a new blood test for the diagnosis of fibrotic NASH
J. Boursier
,
R. Anty
,
L. Vonghia
,
V. Moal
,
T. Vanwolleghem
,
et al.
Alimentary Pharmacology & Therapeutics (Suppl), 2018, 47 (10), pp.1387-1396. ⟨10.1111/apt.14621⟩
Journal articles
hal-02448804v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|